Ferring Research Institute Inc - Company Review
Ferring Research Institute Inc - Company ReviewSummary
Ferring Research Institute Inc (FRI), a subsidiary of Ferring International Center SA is a therapeutic research institute that develops peptide-based drugs. The institute’s products comprise desmopressin, high dose desmopressin, degarelix, terlipressin, carbetocin injection, triptorelin and atosiban. It offers products in therapeutic areas of reproductive health and urology, among others. FRI also provides research laboratories for peptide medicinal chemistry, biochemistry, bioanalytical and pharmacology. The institute has research collaboration with scientific institutes and other pharmaceutical and biotechnology companies. It operates manufacturing facilities in the US, Israel, India and China. FRI is headquartered in San Diego, California, the US.
This comprehensive company report of Ferring Research Institute Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.